Diabetes Care "On Air" Podcast Por American Diabetes Association arte de portada

Diabetes Care "On Air"

Diabetes Care "On Air"

De: American Diabetes Association
Escúchala gratis

OFERTA POR TIEMPO LIMITADO. Obtén 3 meses por US$0.99 al mes. Obtén esta oferta.
Diabetes Care “On Air” is the monthly podcast of the American Diabetes Association’s premier clinical research journal, Diabetes Care. In each episode, co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, interview key authors of editor-selected feature articles and discuss the latest research presented in Diabetes Care. The podcast is intended for diabetes researchers and specialists, endocrinologists, and other health care professionals. Join Alice and Mike as they explore the latest high-impact research and information on diabetes care, treatment, and prevention. To learn more about Diabetes Care, please visit https://diabetesjournals.org/care.Copyright 2022-2023, American Diabetes Association, Inc. Ciencia Ciencias Biológicas Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Carmella Evans-Molina on the heterogeneity of type 1 diabetes, Samuel Seidu with an observational study on older adults with type 2 & the risk of falls, and more!
    Oct 3 2025
    Welcome to episode no. 38 (October 2025) of Diabetes Care “On Air”—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the October 2025 issue of Diabetes Care and beyond. 2:11 Mike is joined by Carmella Evans-Molina, MD, PhD, the Eli Lilly Professor of Pediatric Diabetes at Indiana University, where she is Director of the Indiana Diabetes Research Center. She is first author on the article “The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum,” available for free at doi.org/10.2337/dci25-0013. 18:15 Alice speaks with Professor Samuel Seidu from the Diabetes Research Centre at the University of Leicester in the U.K. His article, “Glucose Control, Sulfonylureas, and Insulin Treatment in Older Adults With Type 2 Diabetes and Risk of Falls and Fractures: An Observational Study,” available for free at doi.org/10.2337/dc25-0517. 35:45 In the “Diabetes Care Rapid Exchange,” Alice and Mike wrap up the episode by reviewing several interesting articles in the October 2025 issue of Diabetes Care. Studies highlighted in this segment include: Chen et al. Stroke Incidence Evolution in People With Newly Diagnosed Diabetes and Impaired Glucose Tolerance: A 34-Year Follow-up of the Da Qing Diabetes Study doi.org/10.2337/dc24-2675 Thapa et al. Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study doi.org/10.2337/dc25-0530 Hong et al. Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes: A Nationwide Retrospective Cohort Study doi.org/10.2337/dc25-0292 Ljungberg et al. Risk of Phimosis Associated With SGLT2i Versus GLP-1RA: A Danish Cohort Study doi.org/10.2337/dc25-0693 Larsson et al. Sight-Threatening Diabetic Retinopathy During and After Pregnancy—A Nationwide Matched-Cohort Study doi.org/10.2337/dc25-0758 Zaharieva et al. Physical Activity Is Associated With Improved Glycemic Outcomes in Newly Diagnosed Youth With Type 1 Diabetes: 4T Exercise Program doi.org/10.2337/dc25-0765 To learn more about Diabetes Care, please visit diabetesjournals.org/care. Interested in submitting cover art to the journal? Please visit https://diabetesjournals.org/care/pages/submit_a_cover_image.
    Más Menos
    50 m
  • Yu Mi Kang on the PCSK9 inhibitor Evolocumab & the FOURIER Trial, Neda Rasouli with insights on semaglutide in symptomatic peripheral artery disease & the STRIDE Trial, and more!
    Sep 5 2025
    Welcome to episode no. 35 (September 2025) of Diabetes Care “On Air”—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the September 2025 issue of Diabetes Care and beyond. 3:05 Alice is joined by Yu Mi Kang, MD, PhD, endocrinologist at Brigham and Women’s Hospital and instructor at Harvard University in Boston. The discuss her article, “Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial,” available for free at doi.org/10.2337/dc25-0942. 14:10 Mike speaks with Neda Rasouli, MD, Professor of Medicine in the Division of Endocrinology, Metabolism, and Diabetes at the University of Anschutz Medical Campus. She shares insights from her article, “Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial,” available for free at doi.org/10.2337/dc25-1082. 27:20 In the “Diabetes Care Rapid Exchange,” Alice and Mike wrap up the episode by reviewing several interesting articles in the September 2025 issue of Diabetes Care. Studies highlighted in this segment include: Templeman et al. Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study doi.org/10.2337/dc25-0192 Yau et al. Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Emergency Department Visits and Hospitalization in Patients With Chronic Kidney Disease doi.org/10.2337/dc24-2811 Turner et al. Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial doi.org/10.2337/dc25-0141 Gordon et al. Diabetes in Pregnancy and School-Age Developmental Outcomes for Offspring: A Statewide Retrospective Cohort Study doi.org/10.2337/dc25-0678 Witkowski et al. Predictors of Diabetes Outcomes at 1 Year After Islet Autotransplantation: Data From a Multicenter Cohort Study doi.org/10.2337/dc25-0620 Maagensen et al. Effect of SGLT2 Inhibition on Glucosuria During a Hyperglycemic Clamp in HNF1A-MODY (MODY3) and Type 2 Diabetes doi.org/10.2337/dc25-0737 To learn more about Diabetes Care, please visit diabetesjournals.org/care. Interested in submitting cover art to the journal? Please visit https://diabetesjournals.org/care/pages/submit_a_cover_image.
    Más Menos
    42 m
  • Special Edition: Highlights from the ADA’s 2025 Scientific Sessions
    Aug 15 2025

    In this special crossover episode, recorded live at the American Diabetes Association’s 85th Scientific Sessions in Chicago, the hosts of ADA’s professional podcasts—Diabetes Core Update, Diabetes Care “On Air”, and DiabetesBio—come together to discuss key highlights and groundbreaking research presented at the 2025 meeting.

    They share expert insights across the bench-to-bedside spectrum, including basic science, clinical research, and the latest in diabetes care and education. Tune in for thoughtful reflections on what this year’s findings mean for clinical practice and future research.

    Available now across all ADA professional podcast channels.

    Featured Podcasts:

    • Diabetes Care “On Air” – From ADA’s clinical research journal, Diabetes Care

    • Diabetes Core Update – ADA’s podcast for primary care

    • DiabetesBio – From ADA’s flagship research journal, Diabetes

    Join the Discussion with:

    • Alice Cheng, MD – Co-host of Diabetes Care “On Air”

    • Kirk Habegger, PhD – Co-host of DiabetesBio

    • Michael Rickels, MD, MS – Co-host of Diabetes Care “On Air”

    • Darleen Sandoval, PhD – Co-host of DiabetesBio

    • Neil Skolnik, MD – Co-host of Diabetes Core Update and Diabetes Day by Day

    • Kevin Williams, PhD – Co-host of DiabetesBio

    🔗 Learn more about ADA’s full podcast portfolio:
    https://diabetesjournals.org/journals/pages/podcasts

    Subscribe to Diabetes Core Update, Diabetes Care “On Air”, and DiabetesBio on Apple Podcasts, Amazon Music, Spotify, or your preferred platform.

    Más Menos
    39 m
Todavía no hay opiniones